ABVC BioPharma, Inc. (ABVC) vs Context Therapeutics Inc. (CNTX)
ABVC BioPharma, Inc. and Context Therapeutics Inc. are both Biotechnology companies. ABVC BioPharma, Inc. and Context Therapeutics Inc. are of similar size ($34.1M and $34.0M). Across the 10 metrics below, ABVC BioPharma, Inc. leads on 6 and Context Therapeutics Inc. on 4.
Valuation
Profitability
| Metric | ABVC | CNTX | Biotechnology median |
|---|---|---|---|
| Gross margin | 99.97% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (65.32%) | (76.14%) | (57.72%) |
| Return on assets | (39.88%) | (68.96%) | (49.22%) |
| Return on invested capital | (33.45%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack